Trials / Active Not Recruiting
Active Not RecruitingNCT07285265
Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
A Randomized, Blinded and Positive-Control Phase I Clinical Trial to Evaluate the Immunogenicity and Safety of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Suzhou Abogen Biosciences Co., Ltd. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to evaluate the tolerability, reactogenicity and safety of 2 injections (approximately 2 months apart) of three different dose levels of ABO1108 in adults aged 40 years or above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ABO1108 | Formulation for injection |
| DRUG | Placebo | 0.9% sodium chloride (normal saline) injection |
| BIOLOGICAL | SHINGRIX | • Formulation for injection |
Timeline
- Start date
- 2025-05-27
- Primary completion
- 2025-11-06
- Completion
- 2026-10-15
- First posted
- 2025-12-16
- Last updated
- 2025-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07285265. Inclusion in this directory is not an endorsement.